27/05/2026
We are proud to share the successful completion of two global Virtual Investigator Meetings supporting our Phase 3 Multiple Myeloma study across the NA/EU and APAC regions.
Each 2-hour session brought together investigators, study teams, and key stakeholders for engaging presentations, collaborative discussions, and interactive Q&A sessions focused on study ex*****on and patient impact.
A special highlight from the APAC meeting was the inclusion of Chinese captions, helping enhance accessibility and engagement for regional participants.
Grateful to everyone involved for the teamwork, preparation, and commitment that made both meetings a success. Excited for the next steps as we continue advancing this important study.